Basic Reglan Information

• INN (International Nonproprietary Name): Metoclopramide.
• Brand Names Available In Canada (English): Not specified in the raw data; internationally listed brands include Reglan, Metozolv ODT, Primperan, Perinorm and Gimoti.
• ATC Code: A03FA01.
• Forms & Dosages: Tablets 5 mg and 10 mg; Orally disintegrating tablets 5 mg and 10 mg; Oral solution 5 mg/5 mL; Injectable solution 5 mg/mL; nasal spray form exists in the USA (Gimoti).
• Manufacturers In Canada (English): Not specified in the raw data; international suppliers include ANI Pharmaceuticals and Bausch Health (USA), Sandoz and Zentiva (Europe), and several Indian manufacturers such as IPCA and Sun Pharma.
• Registration Status In Canada (English): Not specified in the raw data; internationally metoclopramide products are regulated and prescription-only in most jurisdictions.
• OTC / Rx Classification: Prescription-only (Rx) in nearly all jurisdictions due to safety profile and neurological risks.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Many prescribers recommend dividing metoclopramide doses across daytime hours for conditions like gastroparesis or GERD.

Typical adult regimens include metoclopramide 10–15 mg up to four times daily for reflux, with common limits near 60 mg/day.

For diabetic gastroparesis many clinicians use 10 mg up to four times daily with an upper practical limit often around 40 mg/day and short courses are advised.

Shift workers or people with early-morning symptoms should consider a dose 15–30 minutes before the first food intake after waking.

Evening or bedtime doses can be lowered or omitted if drowsiness, vivid dreams, or next-day grogginess occur.

A Friday-evening example: a patient with post-procedure nausea given a single IV dose in the ED often felt symptom relief within an hour.

Keep a clear stop date on the prescription to reduce cumulative risk of tardive dyskinesia with longer use.

Taking With Or Without Meals (Canadian Diet Context)

Metoclopramide is often given 10–30 minutes before meals to speed gastric emptying and reduce post‑prandial symptoms.

Use the oral solution (5 mg/5 mL), tablets (5 mg, 10 mg) or ODT form depending on swallowing ability and morning routines.

High‑fat meals common in some Canadian contexts, such as poutine or heavy breakfasts, slow gastric emptying and make pre‑meal timing more important.

Choose a formulation you can reliably use on busy mornings; ODTs dissolve without water and can be helpful when time is short.

For quick reference: metoclopramide 10 mg before each meal is a common practical approach for symptomatic control.

Tablet Vs solution Vs ODT comparison:

• Tablets (5 mg/10 mg): Easy to carry, standard dosing increments.
• Oral solution (5 mg/5 mL): Useful for dose titration and patients who cannot swallow tablets.
• ODT: Handy for mornings and when water is not available.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Health Canada-style advisories note metoclopramide as prescription-only with neurological risk concerns such as extrapyramidal symptoms and tardive dyskinesia.

Absolute contraindications from the product data include pheochromocytoma, gastrointestinal obstruction, perforation or haemorrhage, prior metoclopramide-induced tardive dyskinesia, uncontrolled epilepsy, and known hypersensitivity.

Relative cautions include Parkinson disease, depression, renal or hepatic impairment, elderly or frail patients, and breastfeeding individuals because the drug passes into breast milk.

Check the Drug Identification Number (DIN) on the label and consult the product monograph when in doubt.

Carry a small wallet card summarizing dose and emergency symptoms if the drug is prescribed.

Activities To Limit (Driving, Workplace Safety)

Metoclopramide can cause drowsiness, akathisia, restlessness and other CNS effects that impair driving and machinery operation.

Avoid driving and operating heavy equipment until individual tolerance is established.

Inform employers if you work in a safety‑sensitive role such as trucking, construction or air‑line operations; document counselling where required for licensing or occupational health.

For acute dystonic reactions or sudden involuntary movements, seek emergency care immediately.

Provide a printable wallet card with emergency contacts, dose information and the DIN for workplace or cross‑jurisdictional documentation.

Dosage & Adjustments

General Regimen (DIN References)

Metoclopramide is available in tablets (5 mg, 10 mg), ODTs, oral solution (5 mg/5 mL) and injectables (5 mg/mL).

Common adult dosing for GERD is 10–15 mg up to four times daily with many clinicians limiting total exposure to 4–12 weeks.

For diabetic gastroparesis typical regimens are 10 mg up to four times daily with many prescribers advising short courses of 2–8 weeks and practical limits nearer 40 mg/day.

Injectable IV doses are used in acute care and are individualized by the prescriber.

Pharmacists and claim forms will often record the DIN to support provincial plan reimbursement (ODB, BC PharmaCare, RAMQ).

Special Cases (Elderly, Comorbidities)

Elderly patients should start at the lower end of the dosing range and be closely monitored for extrapyramidal symptoms and tardive dyskinesia.

Renal impairment requires dose reduction proportional to GFR to avoid accumulation and increased CNS effects.

Hepatic impairment also warrants lower doses and closer monitoring for central nervous system toxicity.

Paediatric dosing is weight‑based and neonates are generally avoided.

Breastfeeding patients should discuss risks with the prescriber because metoclopramide passes into breast milk.

Simple dose-adjustment checklist: reduce dose for age, renal dysfunction, hepatic disease and severe frailty.

User Testimonials

Positive Reports From Canadian Patients

Many patients report rapid relief from acute nausea when given IV metoclopramide in emergency departments or perioperative settings.

Oral formulations — tablets, ODTs and the 5 mg/5 mL solution — are praised for ease of titration at home for brief courses.

Some people with diabetic gastroparesis describe meaningful symptom relief on short courses combined with dietary adjustments such as smaller, lower‑fat meals.

A practical patient story: a person in a rural community received a short oral course and tracked symptom improvement with a meal diary shared at follow‑up.

Common Challenges In Forums (Reddit Canada, Health Boards)

Forum users often report concerns about extrapyramidal side effects such as acute dystonia and longer‑term tardive dyskinesia.

Access problems in rural and remote communities are frequently mentioned — local chains or independents may be out of stock.

Provincial coverage varies and some patients report needing prior authorizations for longer or off‑label use.

Common patient advice: keep a symptom diary, ask for bilingual labels in Quebec, and discuss a clear stop date with the prescriber.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Metoclopramide is prescription-only in most jurisdictions and can be filled at major chains like Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu, or at independent pharmacies.

Ask the pharmacist to confirm the DIN on the dispensed product and to check provincial formulary listing for your indication.

Injectable forms are commonly supplied by hospitals for in‑clinic use, while oral solutions and tablets are standard retail items.

In some cases ODTs are less commonly stocked — request a pharmacy transfer or special order if required.

In our online pharmacy, reglan is available without a prescription, with discreet delivery to Canada in 5-14 days.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Provincial plans and private insurance affect out‑of‑pocket cost; dispensing fees at retail stores add to the base drug price.

Online pharmacies can have lower drug costs but may charge shipping and handling fees; always verify DIN and pharmacy licensure.

Importing drugs from the USA is generally not recommended for routine supply because of CBSA and Health Canada rules and differing product availability.

Bring your prescription, health card and a current allergy list when picking up or transferring a prescription.

What’s Inside & How It Works

Ingredients Overview

The active ingredient in Reglan and generics is metoclopramide (INN).

Available formulations include tablets (5 mg, 10 mg), orally disintegrating tablets, oral solution (5 mg/5 mL) and injectable 5 mg/mL ampoules or vials.

Excipients differ by manufacturer; patients with lactose intolerance or dye/sorbitol sensitivities should ask the pharmacist to check specific product ingredients and the DIN on packaging.

Mechanism Basics

Metoclopramide is a dopamine D2 receptor antagonist with prokinetic properties classified under ATC A03FA01.

It increases lower oesophageal sphincter tone and accelerates gastric emptying, which helps in gastroparesis and some reflux cases and contributes to antiemetic effects.

The dopamine blockade that produces benefit also explains neurological adverse effects such as extrapyramidal symptoms and increased prolactin levels.

Because of these risks, product guidance recommends the lowest effective dose for the shortest duration necessary.

Main Indications

Approved Uses In Canada

Metoclopramide is commonly used for nausea and vomiting, including chemotherapy- or procedure-related nausea, and as a prokinetic for diabetic gastroparesis.

It may be used for refractory GERD in combination with acid suppression for limited durations.

Injectable metoclopramide is used in emergency and procedural settings for acute symptom control.

Health authorities emphasise short‑term use because of tardive dyskinesia risk with prolonged therapy.

Off-Label Uses By Canadian Physicians

Off-label uses can include functional dyspepsia, facilitation of small-bowel intubation and refractory hiccups in specialist settings with informed consent and close monitoring.

Domperidone or erythromycin may be considered as alternatives depending on cardiac history and local availability, with their own safety considerations.

Paediatric off‑label use is weight‑based and cautious; neonates are generally avoided.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Alcohol can increase sedation and other CNS adverse effects of metoclopramide and should be avoided until tolerance is known.

Caffeine may temporarily mask fatigue but does not prevent movement disorders and is not a protective measure.

High‑fat meals slow gastric emptying and can change timing of symptoms; taking metoclopramide 10–30 minutes pre‑meal is more important with high‑fat meals.

Drug Conflicts (Health Canada Database)

Metoclopramide can worsen extrapyramidal effects when combined with other dopamine blockers such as antipsychotics or prochlorperazine.

Co‑administration with CNS depressants (opioids, benzodiazepines) increases sedation risk and warrants caution.

Exercise caution with serotonergic agents and QT‑prolonging drugs and consult the Health Canada drug product database or a pharmacist for individual interaction checks.

Confirm all prescription, over‑the‑counter and herbal medicines during medication reconciliation before starting therapy.

Latest Evidence & Insights

Canadian And International Research Highlights

Recent literature and regulatory updates increasingly recommend restricting metoclopramide to short courses due to cumulative risk of tardive dyskinesia and extrapyramidal symptoms.

Randomized trials and reviews show symptomatic benefit for short‑term relief in diabetic gastroparesis and acute nausea settings, while long‑term benefit is limited by adverse events.

Regulatory advisories reflect cautious use and coverage restrictions for chronic indications on provincial formularies.

Practical Takeaways For Patients

Alternative Choices

Comparable Medicines

Domperidone is a prokinetic alternative used in some settings but may have cardiac safety concerns and restricted availability in certain markets.

Erythromycin is sometimes used as a prokinetic for gastroparesis though tachyphylaxis and GI side effects can limit usefulness.

Ondansetron and prochlorperazine manage nausea effectively but do not accelerate gastric emptying the way metoclopramide does.

For GERD, maximising acid suppression with a PPI and lifestyle/dietary changes is commonly advised before prokinetic escalation.

Pros/Cons Checklist (Patient-Focused)

• Domperidone: Prokinetic without central D2 blockade; QT prolongation risk, availability issues.
• Erythromycin: Stimulates motility; effectiveness wanes and side effects common.
• Ondansetron: Strong antiemetic; not a prokinetic.
• Lifestyle/Diet: Safe and effective for many; may not suffice alone for severe gastroparesis.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Metoclopramide is prescription-only in most jurisdictions and products approved by regulators carry a Drug Identification Number (DIN).

The product monograph tied to the DIN lists indications, contraindications and dosing; check the monograph or a pharmacist for official guidance.

Packaging in Canada may include bilingual labelling depending on manufacturer and distribution channels.

Provincial Drug Plan Nuances (ODB, PharmaCare, RAMQ)

Coverage and restrictions differ by province — Ontario Drug Benefit, BC PharmaCare and RAMQ may list metoclopramide for specific indications with duration limits.

Prior authorizations or special authority requests are sometimes needed for longer‑term or off‑label use.

Pharmacies often assist with paperwork to support formulary claims and transfers, which helps patients in rural areas access specific formulations.

FAQ

Is Metoclopramide Safe For Long-Term Treatment Of Gastroparesis?

Generally no; Health Canada and current guidance recommend short‑term courses due to the risk of tardive dyskinesia and extrapyramidal symptoms.

Discuss alternatives, monitoring, and clear stop dates with your prescriber.

Can I Drive After Taking Metoclopramide?

Avoid driving until you know how metoclopramide affects you because drowsiness and movement disorders can impair safe driving.

If working in safety‑sensitive roles, inform occupational health or your employer and document counselling.

What If I Miss A Dose Or Accidentally Double‑Dose?

If a dose is missed, take it when remembered unless it is near the next scheduled dose; do not double the next dose.

For suspected overdose with drowsiness, confusion, seizures or extrapyramidal reactions seek emergency care immediately.

Will My Provincial Drug Plan Cover Metoclopramide?

Coverage varies by province and indication; check ODB, BC PharmaCare or RAMQ listings and provide the DIN to the pharmacist for claims support.

Guidelines For Proper Use

Canadian Pharmacist Recommendations

Before dispensing, screen for absolute contraindications such as pheochromocytoma, GI obstruction, prior tardive dyskinesia and uncontrolled seizures.

Verify renal and hepatic function and counsel patients to start at the lower end of dosing and to use the shortest effective duration.

Provide a dosing card showing tablet strengths, oral solution concentration (5 mg/5 mL) and injectable concentration (5 mg/mL) for emergencies.

Advise patients to report any involuntary movements and to stop the drug immediately if extrapyramidal symptoms occur.

Provincial Health Authority Advice

Provincial formularies typically advise limited‑duration use and may require documentation for longer therapy.

Encourage enrollment in provincial medication management programs where available and use telepharmacy or chain transfers to maintain continuity in rural areas.

In Quebec, ensure bilingual counselling and bilingual labels or patient leaflets are provided when requested.

Delivery Across Canada (English)